Clinical Trials Browser

mirdametinib × Dermatologic × 1 year × Clear all

NCT06159166 2026-04-13

Mirda

Phase 1/2 Recruiting

CNSDermatologic

NF1

NCT07237100 2025-11-19

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Phase 2 Recruiting

CNSDermatologic

Melanoma, Neurofibromatoses